IM Cannabis

High-Quality Medical Cannabis

Health Tech & Life Sciences
Active
Public Glil Yam Founded 2008
Total raised
$67.0M
Last: PIPE 2025-07
Stage
Public
Founded
2008
Headcount
15
HQ
Glil Yam
Sector
Health Tech & Life Sciences

About

IMC is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain.

Funding history · 10 rounds · $67.0M total

2025-07
PIPE $4.1M
2025-07
Debt Financing $1.0M
2024-11
PIPE $2.1M
2023-10
Debt Financing $950K
2023-01
PIPE $6.7M
2023-01
PIPE $2.0M
2022-10
PIPE $3.0M
2022-08
PIPE $5.0M
2021-05
PIPE $35.0M
2018-05
Undisclosed $9.1M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

medical-cannabis